Evidence map›Paper›PMID 35058105›Full record

ArticleJournal of substance abuse treatment2022

Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX.

Jennifer S Potter, Erin P Finley, Van L King, Holly J Lanham, Susanne Schmidt, Suyen Schneegans, Kristen D Rosen

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jennifer S PotterUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America.
Erin P FinleyUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America; VA Greater Los Angeles Healthcare System, Center for the Study of Healthcare Innovation, Implementation, and Policy, Los Angelos, CA, United States of America.
Van L KingUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America.
Holly J LanhamUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America. Electronic address: lanham@uthscsa.edu.
Susanne SchmidtUniversity of Texas Health Science Center San Antonio, Department of Population Health Sciences, San Antonio, TX, United States of America.
Suyen SchneegansUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America.
Kristen D RosenUniversity of Texas Health Science Center San Antonio, Department of Psychiatry and Behavioral Sciences, San Antonio, TX, United States of America.
The University of Texas Health Science Center at San Antonio · US

Funding

Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUM1TR004538 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ROBERT A CLARK, Kenneth M Hargreaves · 2023 to 2026
$22.3M
NCATS NIH HHS UM1 TR004538NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

objectivesTo address the critical need for opioid use disorder (OUD) treatment by rapidly planning and implementing a statewide DEA X-waiver training initiative expanding office-based OUD treatment in Texas by: (1) facilitating access to buprenorphine waiver trainings to targeted regions and health care providers across the state; and (2) supporting completion of DEA X-waiver requirements.

methodsWe used a transdisciplinary and theory-driven approach to adapt and rapidly scale up an existing, previously successful DEA X-waiver initiative. Pre-implementation activities included a literature review to identify OUD treatment barriers and demographic analyses to identify high-need areas of the state. We used geospatial mapping methods to identify regions with highest point prevalence of opioid-overdose mortality and low access to a buprenorphine provider. The study team used the Replicating Effective Programs (REP) framework developed by the Centers for Disease Control and Prevention to support implementation of evidence-based practices.

resultsIn six months, we trained 451 waiver eligible providers, 133 (29%) of whom received waivers by 6 months post-training. Of the 163 (36.1%) providers who completed the post-waiver evaluation, 97% reported that they were satisfied or very satisfied with the training. Our initiative delivered high quality education to providers and increased the number of waiver trainers in Texas from eight to thirteen.

conclusionsDespite recent changes to the DEA X-waiver process, barriers to treating OUD with buprenorphine remain. Lack of education and experience treating substance use disorders remains a significant factor in limiting clinician comfort in prescribing buprenorphine. The research team successfully adapted a Texas-wide initiative to increase the number of office-based providers eligible to prescribe buprenorphine for OUD from an existing single-site initiative. Attentiveness to barriers pre-implementation and to adaptations during implementation enabled moderate impact across a large network in a short time and facilitated program sustainment.

Indexed as

BuprenorphineOpioid-Related DisordersHealth PersonnelHumansOpiate Substitution TreatmentTexasBuprenorphineBuprenorphine waiverImplementation scienceMedication for opioid use disorder

Identifiers

PMID35058105
PMCPMC9086104
OpenAlexW4200036037

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.